Estimated antiretroviral therapy coverage among children in Eastern Mediterranean (WHO region)
Eastern Mediterranean (WHO region): Estimated antiretroviral therapy coverage among children was 40 in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among children in Eastern Mediterranean (WHO region), 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, estimated antiretroviral therapy coverage among children in Eastern Mediterranean (WHO region) stood at 40. That is the highest value across all 26 years on record.
Compared with earlier readings it is up 17.6% on the previous year and up 150.0% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among children in Eastern Mediterranean (WHO region) peaked at 40 in 2025 and was at its lowest, 0, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among children in Eastern Mediterranean (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0 | — |
| 2001 | 0 | — |
| 2002 | 0 | — |
| 2003 | 1 | — |
| 2004 | 1 | +0.0% |
| 2005 | 2 | +100.0% |
| 2006 | 2 | +0.0% |
| 2007 | 3 | +50.0% |
| 2008 | 5 | +66.7% |
| 2009 | 6 | +20.0% |
| 2010 | 8 | +33.3% |
| 2011 | 8 | +0.0% |
| 2012 | 9 | +12.5% |
| 2013 | 11 | +22.2% |
| 2014 | 14 | +27.3% |
| 2015 | 16 | +14.3% |
| 2016 | 18 | +12.5% |
| 2017 | 20 | +11.1% |
| 2018 | 22 | +10.0% |
| 2019 | 30 | +36.4% |
| 2020 | 31 | +3.3% |
| 2021 | 32 | +3.2% |
| 2022 | 31 | -3.1% |
| 2023 | 34 | +9.7% |
| 2024 | 34 | +0.0% |
| 2025 | 40 | +17.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2 | 0 | 6 | 10 |
| 2010s | 15.6 | 8 | 30 | 10 |
| 2020s | 33.67 | 31 | 40 | 6 |
Countries ranked near Eastern Mediterranean (WHO region)
- 7 Mali 77 compare
- 8 Thailand 76 compare
- 8 Kazakhstan 76 compare
- 8 Netherlands 76 compare
- 11 Tajikistan 75 compare
- 12 Morocco 73 compare
- 13 Ecuador 71 compare
More health data for Eastern Mediterranean (WHO region)
- Total tetanus - number of reported cases, gaps filled 524 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 482 (2025)
- Pertussis - number of reported cases, gaps filled 14,992 (2025)
- Diphtheria - number of reported cases, gaps filled 5,830 (2025)
- Measles - number of reported cases, gaps filled 83,590 (2025)
- Number of neonatal deaths, annual growth rate -2.01 % change on previous year (2024)
- Number of under-five deaths, annual growth rate -2.69 % change on previous year (2024)
- Number of infant deaths, annual growth rate -2.36 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate 6.13 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate 140.84 % change on previous year (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among children in Eastern Mediterranean (WHO region)?
- Estimated antiretroviral therapy coverage among children in Eastern Mediterranean (WHO region) was 40 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among children recorded in Eastern Mediterranean (WHO region)?
- The highest recorded value was 40 in 2025.
- What is the lowest estimated antiretroviral therapy coverage among children recorded in Eastern Mediterranean (WHO region)?
- The lowest recorded value was 0 in 2000.
- How does Eastern Mediterranean (WHO region) rank for estimated antiretroviral therapy coverage among children?
- Eastern Mediterranean (WHO region) ranks 10th out of 13 groups with data for 2025.
- Is estimated antiretroviral therapy coverage among children rising or falling in Eastern Mediterranean (WHO region)?
- Over the last ten years it is up 150.0%. The long-run trend across the full record is volatile.
- Where does this Eastern Mediterranean (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among children. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).